1445883-65-7

Upstream product

• 3240-94-6 N-(2-chlorethyl)morpholine 
• 1445883-64-6 C₁₆H₁₀N₂O₃S 
• 1445883-63-5 C₁₇H₁₂N₂O₃S 
• 1445883-62-4 C₁₇H₁₅N₂O₄S⁽¹⁺⁾*Br^(1-) 
• 2941-72-2 6-methoxy-2-methylbenzothiazole 
• 6274-29-9 2-amino-5-methoxy-thiophenol 
• 1747-60-0 6-methoxybenzothiazol-2-ylamine 

Downstream Products

• 1445883-66-8 C₂₂H₂₃N₃O₂S 
• 1445881-83-3 C₃₀H₃₃N₅O₄S 

Relevant academic research and scientific papers

TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF

The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase.

TRI-HETEROCYCLIC DERIVATIVES, PREPARATION PROCESS AND USES THEREOF

The present invention relates to a tri-heterocyclic derivatives, preparation process and uses thereof, specifically relates to a tri-heterocyclic derivatives of the formula (I) or a pharmaceutically acceptable salt thereof, preparation process, and further relates to a pharmaceutically acceptable composition comprising compounds of formula (I), or a pharmaceutically acceptable salt thereof, and their pharmaceutical use as inhibitors of kinase